Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Adv Exp Med Biol ; 1409: 51-81, 2023.
Article in English | MEDLINE | ID: mdl-36038807

ABSTRACT

A spinal cord injury (SCI) is a very debilitating condition causing loss of sensory and motor function as well as multiple organ failures. Current therapeutic options like surgery and pharmacotherapy show positive results but are incapable of providing a complete cure for chronic SCI symptoms. Tissue engineering, including neuroprotective or growth factors, stem cells, and biomaterial scaffolds, grabs attention because of their potential for regeneration and ability to bridge the gap in the injured spinal cord (SC). Preclinical studies with tissue engineering showed functional recovery and neurorestorative effects. Few clinical trials show the safety and efficacy of the tissue engineering approach. However, more studies should be carried out for potential treatment modalities. In this review, we summarize the pathophysiology of SCI and its current treatment modalities, including surgical, pharmacological, and tissue engineering approaches following SCI in preclinical and clinical phases.


Subject(s)
Spinal Cord Injuries , Tissue Engineering , Humans , Tissue Scaffolds , Spinal Cord Injuries/genetics , Spinal Cord Injuries/therapy , Spinal Cord , Biocompatible Materials , Nerve Regeneration/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...